Anixa Biosciences, Inc.

Healthcare · Biotechnology · United States

Last price 3.12 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 108.46M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to addr...